ExodusPoint Capital Management LP Invests $356,000 in Amedisys, Inc. (NASDAQ:AMED)

ExodusPoint Capital Management LP purchased a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,923 shares of the health services provider's stock, valued at approximately $356,000.

Several other institutional investors have also recently added to or reduced their stakes in AMED. Barclays PLC raised its stake in shares of Amedisys by 49.5% in the 3rd quarter. Barclays PLC now owns 15,529 shares of the health services provider's stock valued at $1,500,000 after purchasing an additional 5,142 shares in the last quarter. Geode Capital Management LLC raised its stake in Amedisys by 1.3% during the third quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider's stock valued at $54,746,000 after buying an additional 7,071 shares in the last quarter. Oddo BHF Asset Management Sas bought a new position in Amedisys during the 3rd quarter worth approximately $7,238,000. Versant Capital Management Inc grew its position in shares of Amedisys by 68.5% in the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after acquiring an additional 183 shares in the last quarter. Finally, HBW Advisory Services LLC acquired a new position in shares of Amedisys in the 4th quarter worth approximately $38,000. 94.36% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Stephens restated an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a research note on Tuesday, March 4th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Amedisys has an average rating of "Hold" and an average price target of $101.00.

Remove Ads

Amedisys Stock Performance

AMED stock traded up $0.14 during midday trading on Tuesday, reaching $91.58. The company had a trading volume of 111,386 shares, compared to its average volume of 401,020. The firm has a market capitalization of $3.00 billion, a PE ratio of 36.34, a P/E/G ratio of 1.78 and a beta of 0.89. The stock has a 50 day moving average price of $92.17 and a 200 day moving average price of $91.98. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The health services provider reported $0.96 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.05 by ($0.09). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $598.05 million for the quarter, compared to analyst estimates of $602.38 million. Analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.